We are live on
!
Find out more
GCP
GSA Capital Partners Portfolio holdings
AUM
$1.59B
1-Year Est. Return
39.81%
This Fund
S&P 500
This Quarter
Est. Return
+33.48%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$611M
AUM Growth
+$11.7M
(+2%)
Cap. Flow
-$91.9M
Cap. Flow
% of AUM
-15.04%
Top 10 Holdings %
Top 10 Hldgs %
4.77%
Holding
1,794
New
573
Increased
263
Reduced
313
Closed
643
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Best Buy
BBY
|
+$2.79M |
| 2 |
Bath & Body Works
BBWI
|
+$2.78M |
| 3 |
Advanced Micro Devices
AMD
|
+$2.7M |
| 4 |
NVIDIA
NVDA
|
+$2.4M |
| 5 |
ExxonMobil
XOM
|
+$2.28M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$10.9M |
| 2 |
State Street SPDR Bloomberg High Yield Bond ETF
JNK
|
+$7.99M |
| 3 |
ORPH
Orphazyme A/S
ORPH
|
+$5.06M |
| 4 |
BridgeBio Pharma
BBIO
|
+$3.35M |
| 5 |
BPY
Brookfield Property Partners L.P. Limited Partnership Units
BPY
|
+$3.25M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 17.42% |
| 2 | Technology | 16.03% |
| 3 | Healthcare | 14.17% |
| 4 | Industrials | 13.91% |
| 5 | Financials | 11.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SC
526
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
| $426K | 0.07% |
+19,340
| New | +$418K |
|
527
AngioDynamics
ANGO
$649M
| $425K | 0.07% |
+27,717
| New | +$352K |
|
528
Ferrari
RACE
$72.5B
| $424K | 0.07% |
+1,849
| New | +$377K |
|
|
EBIX
529
DELISTED
Ebix Inc
EBIX
| $424K | 0.07% |
+11,169
| New | +$314K |
|
|
TRTX
530
TPG RE Finance Trust
TRTX
$618M
| $423K | 0.07% |
+39,831
| New | +$377K |
|
|
DOCU
531
DocuSign
DOCU
$11.5B
| $422K | 0.07% |
+1,898
| New | +$426K |
|
532
MarineMax
HZO
$788M
| $422K | 0.07% |
12,050
-19,774
| -62% | -$619K |
|
|
RC
533
Ready Capital
RC
$308M
| $422K | 0.07% |
+33,930
| New | +$417K |
|
534
Alpha and Omega Semiconductor
AOSL
$1.08B
| $421K | 0.07% |
17,809
-12,650
| -42% | -$258K |
|
535
Aldeyra Therapeutics
ALDX
$93.5M
| $420K | 0.07% |
61,220
+35,717
| +140% | +$251K |
|
|
NVRO
536
DELISTED
NEVRO CORP.
NVRO
| $420K | 0.07% |
+2,426
| New | +$393K |
|
537
GrowGeneration
GRWG
$90.7M
| $419K | 0.07% |
+10,411
| New | +$280K |
|
|
RESN
538
DELISTED
Resonant Inc.
RESN
| $418K | 0.07% |
+157,574
| New | +$372K |
|
|
AL
539
DELISTED
Air Lease Corp
AL
| $417K | 0.07% |
9,398
-2,991
| -24% | -$107K |
|
540
First Busey Corp
BUSE
$2.56B
| $416K | 0.07% |
19,290
+2,736
| +17% | +$53.6K |
|
541
Royal Gold
RGLD
$19.5B
| $416K | 0.07% |
+3,912
| New | +$452K |
|
542
Seagate
STX
$184B
| $415K | 0.07% |
+6,679
| New | +$375K |
|
543
Analog Devices
ADI
$190B
| $414K | 0.07% |
+2,800
| New | +$371K |
|
544
Integra LifeSciences
IART
$1.34B
| $413K | 0.07% |
6,368
+317
| +5% | +$17.1K |
|
545
Saic
SAIC
$5.35B
| $412K | 0.07% |
+4,355
| New | +$383K |
|
546
Viking Therapeutics
VKTX
$4B
| $412K | 0.07% |
73,099
+62,198
| +571% | +$377K |
|
547
BrightView Holdings
BV
$1.07B
| $411K | 0.07% |
27,182
-2,797
| -9% | -$38.3K |
|
548
iShares Russell Mid-Cap Growth ETF
IWP
$20.7B
| $411K | 0.07% |
+4,001
| New | +$381K |
|
549
TFS Financial
TFSL
$4.93B
| $411K | 0.07% |
+23,300
| New | +$388K |
|
550
CTS Corp
CTS
$1.89B
| $410K | 0.07% |
+11,932
| New | +$353K |
|
Similar funds
NCL
DG
VNT
SS
GWANC
LCM
LCM
FDCP
GSA Capital Partners's Q4 2020 Portfolio in Review
As of Q4 2020, GSA Capital Partners held 1,794 positions worth $611M, up 2% from $600M the previous quarter. Its ten largest holdings account for 4.8% of the portfolio.
GSA Capital Partners withdrew a net $91.9M in Q4 2020, closing 643 positions and reducing 313 holdings. Its most notable exit was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $10.9M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.
Against the trend, GSA Capital Partners opened a new position in Best Buy worth $2.49M.
- GSA Capital Partners's largest Q4 2020 buy was Best Buy: 24,945 shares worth $2.49M.
- GSA Capital Partners added most to Advanced Micro Devices in Q4 2020, an estimated $2.7M increase.
- GSA Capital Partners's biggest Q4 2020 reduction was BridgeBio Pharma, cutting an estimated $3.35M.
- GSA Capital Partners fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q4 2020, selling an estimated $10.9M.
- GSA Capital Partners's ten largest holdings make up 4.8% of its $611M portfolio in Q4 2020.
- GSA Capital Partners opened 573 new positions and closed 643 in Q4 2020.
- GSA Capital Partners's portfolio value rose 2% quarter-over-quarter to $611M.
Based on GSA Capital Partners's 13F filing for Q4 2020, filed 3 Feb 2021.